top of page
![Pattern 5 [Converted]-01.png](https://static.wixstatic.com/media/51c62d_44f38c257d614130ace0f56455e9be12~mv2.png/v1/fill/w_980,h_718,al_c,q_90,usm_0.66_1.00_0.01,enc_avif,quality_auto/51c62d_44f38c257d614130ace0f56455e9be12~mv2.png)
Knowledge Center
Search
AI-enabled opportunistic measurement of liver steatosis in coronary artery calcium scans predicts cardiovascular events and all-cause mortality:
Research shows HeartLung.AI’s AI-CVD™ improves traditional calcium scores in predicting heart disease risk and all-cause mortality
HeartLung Technologies Secures CMS Reimbursement for AutoChamberâ„¢ with New HCPCS Code
CMS has approved a new HCPCS code for AutoChamberâ„¢ AI reporting cardiac chambers volume and left ventricular mass in existing CT scans.
HeartLung Technologies welcomes medical imaging and bioengineering expert Dr. Zahi A. Fayad, PHD, to the Advisory Board
HeartLung Technologies welcomes medical imaging and bioengineering expert Dr. Zahi A. Fayad, PHD, to the Advisory Board.
HeartLung Technologies Presented 3 Groundbreaking AI Studies at BMEII 2025 New York Academy of Medicine
HeartLung showcases AI innovations at BMEII 2025, advancing healthcare with three scientific presentations.
HeartLung Technologies to launch AutoChamberâ„¢ AI at ACC 2025 and begin offering the AI services to healthcare providers
HeartLung Technologies to launch AutoChamberâ„¢ AI at ACC 2025 and begin offering the AI services to healthcare providers
HeartLung Technologies Selected as a Finalist for ACC 2025 Innovation Pitch Challenge
HeartLung Technologies Selected as a Finalist for ACC 2025 Innovation Pitch Challenge
SimonMed Imaging Partners with HeartLung.AI to Offer Artificial Intelligence-Based Osteoporosis Screening (AutoBMDâ„¢ AI) as an add-on to CT Scans Nationwide
SimonMed Imaging partners with HeartLung.AI to roll out AutoBMDâ„¢ AI for osteoporosis screening, enhancing preventive healthcare.
Part 23 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 2 Session 1: Mobile Vans
Dr. Robert Headrick discusses the evolution and success of mobile lung screening, highlighting key challenges and future innovations.
Part 22 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 2 Session 1: Tribute to Dr. James P. Smith
Honoring Dr. James P. Smith: A tribute to his contributions to LCAP, his enduring legacy in medical screening practices, and his family.
Paradigm shift in early detection: Lung cancer screening to comprehensive CT screening
This study indicates that comprehensive lifestyle modifications can significantly reduce cardiovascular risk factors.
Expert Panel Discusses AI-Driven Innovations in Cardiovascular Imaging: Key Takeaways from RSNA 2024
Experts at RSNA 2024 discuss AI's transformative impact on cardiovascular imaging, featuring insights from HeartLung.AI., Nurea, AI4MedImagi
Part 21 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 3: Reinventing Public Health in the Era of AI
Dr. Cheryl Healton, DrPH, emphasizes AI's role in public health, expanding lung screening, and managing smoking-related illnesses.
Part 20 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 3: Panel Discussions
Panel highlights advanced imaging and AI in early disease detection, emphasizing standardized reporting and insurance for preventive measure
Part 19 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Sess 3: Sex and Race Differences in Visceral Fat and CVD
Dr. Susan K. Fried, PhD, highlights how sex and race differences in visceral fat impact cardiovascular disease and diabetes risk.
Harmonizing Healthcare and Innovation: HeartLung Technologies Welcomes Dr. Robert A. Kloner to the Advisory Board
HeartLung Technologies welcomes Dr. Robert A. Kloner to the Advisory Board. Discover his contributions to heart health and his music.
Part 18 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 3: Abnormal Adiposity
Dr. Jeffrey Mechanick, MD, redefines abnormal adiposity, linking ectopic fat to cardiometabolic diseases and urging lifestyle changes.
Osteoporosis screening gets another push from The U.S. Preventive Services Task Force (USPSTF) — HeartLung's AutoBMD™ offers a safer, radiation-free alternative
USPSTF endorses DEXA for osteoporosis. HeartLung's AutoBMDâ„¢ offers a safer, radiation-free alternative.
Part 17 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 3: Osteoporosis and Sarcopenia
Dr. Mingqian Huang, MD, emphasizes the critical role of advanced imaging and AI in detecting and managing osteoporosis and sarcopenia.
Part 16 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 3: Fatty Liver Disease
Dr. Andrea D. Branch, PhD, highlights CT screening for liver steatosis, a metabolic syndrome marker, and the role of new drugs in treatment.
HeartLung’s 2024 Year in Review - Milestones and Pipeline for 2025
2024 was a monumental year for HeartLung Technologies. With that being said, we have exciting developments for 2025!
bottom of page